Skip to content

    DHANSA Q4 FY26 earnings call

    DHANSA
    Chemicals·5 Jun 2026
    Management Summary

    Dhansa Labs Limited reported a strong Q4 FY26 with double-digit revenue and PAT growth, driven by operational efficiency. The company is aggressively expanding its agrochemical business with a Rs. 30 crore Atrazine project and diversifying into green energy with a Rs. 120 crore CBG project, targeting commercial operations by July 2027. However, concerns were raised regarding increased trade receivables due to export delays, the standalone net profit figure, and the initial losses/non-operational status of new subsidiaries.

    Highlights

    5

    • Revenue from operations increased by 10.82% year-on-year to Rs. 14,153.72 lakhs.

    • EBITDA stood at Rs. 1,221.80 lakhs, registering a growth of 6.31%.

    • PAT increased by 15.47% to Rs. 552.26 lakhs.

    • Atrazine project, with an estimated investment of Rs. 30 crores, is projected to add Rs. 120-140 crores in annual revenues upon stabilization.

    • The 15 TPD Compressed Biogas (CBG) project, with an estimated cost exceeding Rs. 120 crores, is expected to commence commercial operations by July 2027.

    Concerns

    4

    • Standalone net profit for FY26 was around Rs. 3.73 crores, lower than the consolidated PAT.

    • Trade receivables jumped by nearly Rs. 13 crores due to export delays caused by ongoing wars.

    • Dhansa Green Energy Private Limited reported zero revenue and a loss of Rs. 21 lakhs.

    • Dhansa Biofuels Power Private Limited has not yet started operations.

    Key financials

    Metrics

    6

    Periods

    2

    Headline

    5
    • Revenue from Operations
      14,153.72 lakhs
      YoY+10.8%
    • EBITDA
      1,221.8 lakhs
      YoY+6.3%
    • PAT
      552.26 lakhs
      YoY+15.5%
    • EBITDA Margin
      8.6%
    • PAT Margin
      3.9%

    FY26

    1
    • Standalone Net Profit
      ₹3.73 Cr

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Guidance & targets

    6
    CategoryTargetPriority
    Revenue
    Additional annual revenue from Atrazine project
    Rs. 120-140 crores
    		High
    Revenue
    Initial revenue from Atrazine project
    Rs. 40 crores
    		High
    Project Timeline
    CBG project commercial operations
    July 2027
    		High
    Revenue Growth
    Overall revenue growth
    about 20%
    		Medium
    Capacity Utilization
    Current capacity utilization
    70-75%
    		High
    Production
    CBG project production
    18 tons per day
    		High

    What to watch in Q1 FY27

    4

    Atrazine Project Initial Revenue

    H1 FY27
    CurrentInitial start target of approx Rs. 40 crores expected this year
    TargetAchieve Rs. 40 crores

    Why it matters

    Verifies initial progress and revenue contribution from a key agrochemical expansion project.

    However, we will this year achieve the initial start target of approximately Rs. 40 crores expected.

    Risks & concerns

    3
    RiskSeverity

    Increased trade receivables due to export delays

    Trade receivables jumped by nearly Rs. 13 crores due to material delays at port levels and ongoing wars, impacting payments and export consignments. Management expects normalization in H1 FY27. — Analyst acknowledged

    medium

    Impact of reduced finished goods prices on sales growth

    Sales growth was not as strong as expected because prices of finished goods had reduced over time, although prices are now starting to increase again. — Management acknowledged

    medium

    Initial losses and non-operational status of new subsidiaries

    Dhansa Green Energy reported a loss of Rs. 21 lakhs with zero revenue, and Dhansa Biofuels has not yet started operations. Management explained these are long-term strategic investments with future benefits like biofertilizers and carbon credits. — Analyst acknowledged

    low

    Q&A highlights

    6

    “See, the proposed project of Atrazine, the estimated investment of approximately Rs. 30 crores is planned. We intend to stabilize this particular project or start this project by August this year and it shall get stabilized by the end of the year and the next year would be primarily the real revenue generation from this of about Rs. 120-140 crores. However, we will this year achieve the initial start target of approximately Rs. 40 crores expected.”

    Provides specific financial and operational targets for a key expansion project, including investment, timeline, and revenue contribution.

    asked by Ankit

    2 min read5 chapters

    Detailed Narrative

    01

    Q4 FY26 Financial Performance Overview

    Dhansa Labs Limited reported a robust financial performance for FY26, with revenue from operations increasing by 10.82% year-on-year to Rs. 14,153.72 lakhs. EBITDA grew by 6.31% to Rs. 1,221.80 lakhs, and PAT saw a significant rise of 15.47% to Rs. 552.26 lakhs. The company maintained an EBITDA margin of 8.55% and a PAT margin of 3.87%, reflecting a continued focus on operational efficiency and cost discipline.

    02

    Agrochemical Business Expansion: Atrazine Project

    The company is undertaking a significant capacity expansion in its core agrochemical business, specifically with the addition of Atrazine manufacturing capacity. This project involves an estimated investment of approximately Rs. 30 crores. Management expects this expansion to enhance market position, improve product diversification, and contribute Rs. 120-140 crores in additional annual revenues upon stabilization. An initial revenue target of Rs. 40 crores is expected this year, with the project stabilizing by year-end.

    03

    Diversification into Green Energy: Compressed Biogas (CBG) Project

    Dhansa Labs is diversifying into the renewable energy sector through its subsidiary, Dhansa Green Energy Private Limited. The company is developing a 15 TPD Compressed Biogas (CBG) project with an estimated project cost exceeding Rs. 120 crores. Commercial operations are targeted to commence by July 2027. This initiative is seen as a foundational step for a scalable green energy platform, positioning the group in a promising sustainability-driven industry.

    04

    Strategic Raw Material Sourcing: Napier Grass Cultivation

    To support the CBG project, Dhansa Labs plans to cultivate Napier grass, aiming to secure a reliable and sustainable feedstock ecosystem. The company has acquired 17 acres for the plant and leased 350 acres for cultivation, with significant land availability (3,500-4,000 acres) in the Bundi district of Rajasthan for future scalability. Napier grass offers stable raw material costs and contributes to carbon credits, reinforcing the company's commitment to sustainability.

    05

    Working Capital and Profitability Concerns Addressed

    An analyst raised concerns about a standalone net profit of Rs. 3.73 crores for FY26 and a jump in trade receivables by Rs. 13 crores. Management clarified that the increase in debtors was due to export delays caused by ongoing wars, expecting normalization in the first half of the current fiscal year. They also noted that IPO funds were utilized to reduce creditors, increase stock levels, and fund CAPEX, addressing issues of material availability and capacity utilization in agrochemicals.

    This is an AI-generated summary of a publicly available earnings call transcript.